Selected Publications

C. J. Moody and E. Swann, Novel Bioreductive Anticancer Agents Based on Indolequinones. Farmaco, 1997, 52, 271-279.

M. A. Naylor, E. Swann, S. A. Everett, M. Jaffar, J. Nolan, N. Robertson, S. D. Lockyer, K. B. Patel, M. F. Dennis, M. R. L. Stratford, P. Wardman, G. E. Adams, C. J. Moody, and I. J. Stratford, Indolequinone Anti-tumor Agents: Reductive Activation and Elimination from (5-Methoxy-1,2-dimethyl-4,7-dioxo-indol-3-yl)methyl Derivatives and Hypoxia-Selective Cytotoxicity in vitro. J. Med. Chem., 1998, 41, 2720-2731.

H. D. Beall, S. Winski, E. Swann, A. R. Hudnott, A. S. Cotterill, N. O'Sullivan, S. J. Green, R. Bien, D. Siegel, D. Ross, and C. J. Moody, Indolequinone Antitumor Agents: Correlation between Quinone Structure, Rate of Metabolism by Recombinant Human NQO1 and in vitro Cytotoxicity. J. Med. Chem., 1998, 41, 4755-4766.

S. A. Everett, M. A. Naylor, P. Barraja, E. Swann, K. B. Patel, M. R. L. Stratford, A. R. Hudnott, B. Vojnovic, R. J. Locke, P. Wardman, and C. J. Moody, Controlling the rates of reductively activated elimination from the (indol'3'yl)methyl position of indolequinones. J. Chem. Soc., Perkin Trans. 2, 2001, 843-860.

M. Faig, M. A. Bianchet, S. Winski, R. Hargreaves, C. J. Moody, A. R. Hudnott, D. Ross, and L. M. Amzel, Structure-based development of anticancer drugs: Complexes of NAD(P)H:quinone oxidoreductase 1 with chemotherapeutic quinones. Structure, 2001, 9, 659-667.